Table 1.
Clinicopathological variables for CEACAM1-expression and non CEACAM1-expression groups.
| Variable | Non CEACAM1-expression N = 78 |
CEACAM1-expression N = 157 |
p-value |
|---|---|---|---|
| Age (Median, Range) | 66 (23–90) | 69 (37–89) | 0.059 |
| Gender (male/female) | 51/27 | 119/38 | 0.121 |
| Differentiation (diffuse/intestinal) | 56/22 | 42/115 | <0.001 |
| Depth (T1,T2/T3,T4) | 49/29 | 96/61 | 0.887 |
| Stage (I,II/III) | 60/18 | 128/29 | 0.489 |
| Lymph node metastasis (+/−) | 32/46 | 62/85 | 0.888 |
| Lymphatic permeation (+/−) | 38/40 | 87/70 | 0.405 |
| Venus permeation (+/−) | 21/57 | 67/90 | 0.022 |